中文 | English
Return
Total: 54 , 1/6
Show Home Prev Next End page: GO
Author:(Lü-Nan YAN)

2.Current status and prospect of liver transplantation for hepatocellular carcinoma.

Lü-Nan YAN

Acta Academiae Medicinae Sinicae 2005;27(4):427-430

4.Feasibility of small size graft following living donor liver transplantation.

Xiang LAN ; Bo LI ; Xiao-fei WANG ; Ci-jun PENG ; Yong-gang WEI ; Lü-nan YAN

Chinese Journal of Surgery 2009;47(16):1218-1220

5.Combined indocyanine green test and standard remnant liver volume to predict post-hepatectomy hepatic insufficiency for the patients with hepatocellular carcinoma.

Zheng-gui DU ; Bo LI ; Xi FENG ; Jie YIN ; Lü-nan YAN ; Tian-fu WEN ; Yong ZENG

Chinese Journal of Surgery 2010;48(3):189-192

7.Liver transplantation for hepatic metastatic pancreatic insulinoma with a survival over five years.

Xiao-Bo CHEN ; Jie YANG ; Ming-Qing XU ; Lü-Nan YAN

Chinese Medical Journal 2012;125(15):2768-2771

9.Evaluation of effect of community-based HIV/AIDS interventions among men who have sex with men in eighteen cities, China.

Gang ZENG ; Yan XIAO ; Peng XU ; Nan FENG ; Can-rui JIN ; Fan LÜ

Chinese Journal of Preventive Medicine 2009;43(11):977-980

10.Recombinant adenovirus-mediated overexpression of TIMP-1 effectively suppresses hepatocellular carcinoma cell line HepG2 in vitro and in vivo.

Dong XIA ; Liang XU ; Hua FU ; Xiao-Long QI ; Yi QUAN ; Lü-Nan YAN

Chinese Journal of Oncology 2007;29(11):813-817

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 54 , 1/6 Show Home Prev Next End page: GO